MedTrace Logo

A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.

NCT01594554 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2012-05-10

No results posted yet for this study

Summary

A 5-year study to observe and describe long-term patient management and treatment patterns with associated outcomes of patients who previously enrolled in Protocol AI452009 (i.e., the CCgenos cross sectional phase, ClinicalTrials.gov Identifier: NCT01293279) and had their genotype characterized at diagnosis of HCV infection in a real world clinical practice in China.

Conditions

  • Hepatitis C

Sponsors & Collaborators

Principal Investigators

  • Hong Li, Ph.D · Bristol-Myers Squibb

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2016-04-30
Completion
2016-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01594554 on ClinicalTrials.gov